Skip to main content
. 2019 Nov 11;176(Suppl 1):S247–S296. doi: 10.1111/bph.14751
Nomenclature http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1287 http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2897
Common abbreviation GC‐1 GC‐2
Subunits http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1290, http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1288 http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1290, http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1289
EC number http://www.genome.jp/dbget‐bin/www_bget?ec:4.6.1.2 http://www.genome.jp/dbget‐bin/www_bget?ec:4.6.1.2
Endogenous ligands http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2509 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2509
Selective activators http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9900 (pEC50 6.6) [http://www.ncbi.nlm.nih.gov/pubmed/29643251?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5291 [http://www.ncbi.nlm.nih.gov/pubmed/9003762?dopt=AbstractPlus, http://www.ncbi.nlm.nih.gov/pubmed/7527671?dopt=AbstractPlus, http://www.ncbi.nlm.nih.gov/pubmed/9742221?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5168 [apo‐GC‐1] [http://www.ncbi.nlm.nih.gov/pubmed/12086987?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10213 [http://www.ncbi.nlm.nih.gov/pubmed/29859918?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5257 [http://www.ncbi.nlm.nih.gov/pubmed/11242081?dopt=AbstractPlus, http://www.ncbi.nlm.nih.gov/pubmed/19089334?dopt=AbstractPlus] http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5291 [http://www.ncbi.nlm.nih.gov/pubmed/7527671?dopt=AbstractPlus, http://www.ncbi.nlm.nih.gov/pubmed/9742221?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5168 [apo‐GC‐2] [http://www.ncbi.nlm.nih.gov/pubmed/12086987?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10213 [http://www.ncbi.nlm.nih.gov/pubmed/29859918?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5257 [http://www.ncbi.nlm.nih.gov/pubmed/11242081?dopt=AbstractPlus, http://www.ncbi.nlm.nih.gov/pubmed/19089334?dopt=AbstractPlus]
Selective inhibitors http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6554 (pIC50 8.1) [http://www.ncbi.nlm.nih.gov/pubmed/9489619?dopt=AbstractPlus] – Bovine, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5234 (pIC50 7.5) [http://www.ncbi.nlm.nih.gov/pubmed/7544433?dopt=AbstractPlus] http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5234